These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 9860409

  • 1. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M, Kolle L, Soriano G, Ortiz J, Pamplona J, Novella MT, Villanueva C, Sainz S, Torras J, Balanzó J, Guarner C.
    Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
    [Abstract] [Full Text] [Related]

  • 2. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
    Fernández J, Ruiz del Arbol L, Gómez C, Durandez R, Serradilla R, Guarner C, Planas R, Arroyo V, Navasa M.
    Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
    [Abstract] [Full Text] [Related]

  • 3. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
    Novella M, Solà R, Soriano G, Andreu M, Gana J, Ortiz J, Coll S, Sàbat M, Vila MC, Guarner C, Vilardell F.
    Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
    [Abstract] [Full Text] [Related]

  • 4. [Prospective randomized trial of intravenous ciprofloxacin for prevention of bacterial infection in cirrhotic patients with esophageal variceal bleeding].
    Hong SN, Kim BJ, Lee SY, Lee CY, Ryu MK, Choi MS, Lee JH, Rhee PL, Koh KC, Kim JJ, Paik SW, Rhee JC, Choi KW.
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):288-96. PubMed ID: 12499786
    [Abstract] [Full Text] [Related]

  • 5. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J, Vila MC, Soriano G, Miñana J, Gana J, Mirelis B, Novella MT, Coll S, Sábat M, Andreu M, Prats G, Solá R, Guarner C.
    Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection.
    Pauwels A, Mostefa-Kara N, Debenes B, Degoutte E, Lévy VG.
    Hepatology; 1996 Oct; 24(4):802-6. PubMed ID: 8855179
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [An analysis of hospital bacterial infections in cirrhotic patients undergoing selective intestinal decontamination].
    Tomás A, Soriano G, Guarner C, Teixidó M, Méndez C, Tena F, Fábrega E, Villanueva C, Such J, Balanzó J.
    Rev Esp Enferm Dig; 1991 Apr; 79(4):259-64. PubMed ID: 2054213
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis.
    Lontos S, Gow PJ, Vaughan RB, Angus PW.
    J Gastroenterol Hepatol; 2008 Feb; 23(2):252-5. PubMed ID: 17559367
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
    Itha S, Sharma A, Bhatt G.
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1634. PubMed ID: 16928235
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S, Kollaras P, Giannakakis T, Seitanidis B, Kordosis T, Nikolaidis J, Hatzitolios A, Nikolaidis P.
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevention of infectious complications after transjugular intrahepatic portosystemic shunt in cirrhotic patients with a single dose of ceftriaxone.
    Gulberg V, Deibert P, Ochs A, Rossle M, Gerbes AL.
    Hepatogastroenterology; 1999 Dec; 46(26):1126-30. PubMed ID: 10370679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.